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Tissue engineering and regenerative medicine aim to 
develop replacement tissues for our body1. Various cell 
types, biomaterials and stimulatory signals (for example, 
growth factors and mechanical signalling), either alone 
or in combination, have been explored for their poten-
tial to support tissue repair and regeneration and to rec-
reate the structure and/or function of tissues. Progress 
in cell and material technologies, such as automation of 
cell culture, techniques for cell selection and new mate-
rial formulations for photolithography and bioprinting, 
has led to the development of more efficient therapies 
for the repair of simple tissues in the laboratory and in 
preclinical models. However, self- sustaining solutions 
that facilitate full tissue integration and homeostasis in 
a timely manner remain elusive2,3.
Biofabrication technologies enable the fabrication of 
biological constructs with precise control over the posi-
tioning of cells and biomaterials (Box 1). Bioprinting and 
bioassembly constitute the two major biofabrication 
pillars, and various techniques have been developed 
(Figs. 1, 2). Bioprinting allows the spatial arrangement of 
cells, materials and biologically active factors, whereas 
bioassembly facilitates the automated assembly of cell- 
containing building blocks4. These techniques provide 
a high level of biomimicry by recreating the complex-
ity of tissues and organs, and they can be upscaled for 
manufacturing and production. Importantly, biofabri-
cation strategies allow the spatiotemporal modulation 
of cell–cell and cell–extracellular matrix (ECM) interac-
tions5,6 through the formulation and use of engineered 
materials, such as hydrogels, that enable cells to migrate 
and that can be remodelled for ECM deposition. In 
bioprinting, the synthetic or natural materials used to 
recreate tissues are processed together with cells and/or 
biomolecules and are often termed bioinks.
High spatial and temporal resolution is important for 
the fabrication of complex tissues for therapies and for 
the creation of 3D in vitro models to investigate biological 
processes7–9. Traditional approaches to fabricating engi-
neered scaffolds, such as porogen leaching or gas foam-
ing, do not allow for the simultaneous incorporation of 
biologi cally relevant signals and cells with high spatial 
control. Biofabrication technologies can be used to pattern 
cells and materials at such high resolution; however, whole 
organ regeneration is not yet possible. Better control over 
the biological processes guiding tissue regeneration needs 
to be achieved, and materials and technologies need to be 
developed that can adequately and dynamically replicate 
these processes at (sub)cellular resolution.
In this Review, we discuss biofabrication technologies 
in the context of tissue and organ models and implant-
able constructs. We highlight advances in biomaterials 
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engineering for bioprinting and bioassembly and 
investigate bioinks for their ability to address chal-
lenges regarding compatibility with different printing 
 technologies and functionality.
Bioink development and processing
Biomaterials can be derived from natural or synthetic 
materials and can be static or dynamic; for example, mate-
rials can be biodegradable through hydrolysis or enzy-
matic degradation. Biomaterials with complex, dynamic 
functionality can be created using chemistries such as 
photo- mediated degradation or crosslinking10. High- 
throughput screening of different material variations11 
enables the rapid design of specific material formulations, 
and various biomaterials are in use as cell- instructive and 
biomimetic environments for regenerative medicine12–14.
Materials used in biofabrication must meet specific 
criteria, depending on the respective technique (for 
example, extrusion or inkjet bioprinting, photopattern-
ing and lithography or formation and assembly of mod-
ular components (Figs. 1, 2, 3)). The spatial resolution 
of bioprinted structures ranges from the nanometre to 
the millimetre scale and is dependent on the biofabri-
cation technology15. Biomaterials termed bioinks refer 
to biomaterials that incorporate cells.
Biomaterials for extrusion bioprinting
Extrusion- based bioprinting is one of the most com-
monly used biofabrication techniques (Figs. 1, 2a). In 
this technique, a material must exhibit steady flow until 
deposition and must rapidly stabilize upon delivery. 
Historically, material formulations used in bioprinting 
have been dominated by materials that rapidly stabilize 
from a non- viscous state, for example, alginate, which 
is rapidly crosslinked by calcium ions, and gelatin- 
methacrylate (GelMA), which crosslinks through cooling 
or light16–18 (Fig. 2b). Because of its innate biofunctionality 
and tunability, GelMA has been used alone or in 
combination with silk fibroin for the bioprinting of 
constructs with optimized biophysical properties19,20. 
Alginate continues to be useful in stabilizing other 
materials to enable inkjet printing of silk fibroin21,22 
or to support hetero geneous, multimaterial extrusion 
techniques. Modifications to printer hardware, such as 
photopermeable nozzles and switchable print heads fed 
from multiple reservoirs, will expand the possibilities for 
materials23 and complexity22,24 in biofabrication.
Supramolecular materials as bioinks
Materials crosslinked by physical, non- covalent bonds 
have increased solution viscosity and thus exhibit shear 
thinning during flow. For example, hydrogen bonds 
in β- sheets of recombinant spider silk proteins25 or in 
guest–host interactions of β- cyclodextrin or adaman-
tane in modified hyaluronic acid (HA) polymers26 
are broken under shear stress, enabling bioprinting 
by extrusion, which is followed by rapid stabilization 
upon deposition. Covalent crosslinking can then be 
applied to stabilize the structure. Supramolecular DNA 
hybridization has also been used in combination with 
inkjet bioprinting to crosslink polypeptides that are 
functionalized with single- stranded DNA, resulting in 
a material that can be degraded by either proteases or 
nucleases27. Alternatively, complementary peptide bind-
ing domains can be grafted onto polymers, such as algi-
nate, to maintain a homogeneous cell suspension and to 
help shield cells from shear stress during the extrusion 
process. In the case of modified alginate, calcium can 
provide a  stabilizing secondary crosslink upon extru-
sion28. Finally, bioinks made of short, self- assembling 
peptides form soft, injectable hydrogels and thus offer 
possibilities for customized bioprinted constructs owing 
to their ease of functionalization29.
Hydrogels as support materials
Shear- thinning hydrogels and viscoplastic materials can 
be used as dynamic support materials for  bioprinting. 
For example, the printed material can be directly depos-
ited into a reservoir of support material30, or alterna-
tively, poloxamers can be extruded to create a pattern 
of divergent and convergent channels31. Hydrogel inks 
can also be directly deposited into a gelatin–particle 
slurry by the use of granular medium that fluidizes 
upon the movement of the print head. This approach 
can be applied to support physiological structures with 
large void spaces, such as heart constructs32 (Fig. 4a). 
Similarly, jammed carbomer microparticles33 can sup-
port the printing of complex structures, such as hier-
archical multiscale branching structures, which cannot 
be bioprinted without support (Fig. 4b). A self- healing 
support hydrogel can be designed by introducing supra-
molecular guest–host modifications, which enable rear-
rangement of the polymeric network and thus adaption 
to the bioprinted material34. This approach allows the 
Box 1 | Biofabrication
Biofabrication
in regenerative medicine, biofabrication is the automated generation of structurally 
organized, biologically functional products from living cells, bioactive molecules, 
biomaterials, cell aggregates such as microtissues or hybrid cell- material constructs 
through bioprinting or bioassembly, and subsequent tissue maturation processes4,15.
Bioprinting
Bioprinting is the use of computer- aided transfer processes for the patterning and 
assembly of living and non- living materials with a defined 2D or 3D architecture to 
produce bioengineered structures for regenerative medicine, pharmacokinetic and 
basic cell biology studies. this includes the additive manufacturing of scaffolds 
designed to control cell activity for tissue repair or regeneration (for example, through 
hierarchical structure or surface engineering).
Bioassembly
Bioassembly is the fabrication of hierarchical constructs with a defined 2D or 3D 
organization through automated assembly of preformed cell- containing fabrication 
units generated through cell- driven self- organization or assembly of hybrid cell- 
material building blocks, which is typically done by applying microfabricated moulds 
or microfluidics4,15.
Biomaterials
Biomaterials are used as (part of) a medical device or an advanced medical product to 
replace, restore or regenerate a tissue or organ and its function15. Biomaterials 
comprise non- toxic synthetic or natural polymers, such as hydrogels (water- swollen 
polymer networks), extracellular matrices, shape memory materials, ceramics and 
metals. If biomaterial properties are designed to modulate cell activity in vitro and 
in vivo, they are referred to as instructive biomaterials.
Bioinks
Bioinks are biomaterials that are processed by bioprinting and that contain biological 
molecules and/or cells15.
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disposition of arbitrary, high- resolution structures in 3D 
(Fig. 4c). A bisphosphonate- modified HA, crosslinked 
through coordination with calcium ions, can also serve 
as support material35.
The use of support materials enables the direct pat-
terning of structures and functionalities into hydrogels34,35, 
the creation of fine channels31–34,36,37 and the deposition 
of hydrogel structures with large internal voids32–34. 
Bioprinting into a granular medium allows the fabrica-
tion of structures from a range of materials and supports 
scaffold- free deposition of cells38, facilitating the direct 
deposition of cell aggregates39. Therefore, the amount of 
biomaterial required to deposit cells can be reduced to 
better reflect the architecture of native tissues40. For exam-
ple, cell- sheet-based bioinks41 enable the bioprinting of 
cell aggregates to compose dense cellular structures42.
High- viscosity and low- viscosity materials
The deposition of highly viscous, thixotropic43 and non- 
viscous materials has been facilitated through adaptions 
in the curing process during bioprinting23. Viscous inks 
exhibiting kinetics that prevent deposition in the solution 
phase can be extruded as microparticles, which are cured 
before deposition. For example, poly(dimethylsiloxane) 
(PDMS) microspheres have a long cure time. When wet-
ted with a thin layer of uncured liquid precursor, the par-
ticles are held together through capillary action, which 
enables their curing into robust, elastomeric structures43. 
Low degrees of covalent crosslinking of low- viscosity solu-
tions before extrusion also facilitate the precise control of 
rheological properties of bioinks to ensure printability; for 
example, gelatin and fibrinogen can be crosslinked with 
an amine- reactive polyethylene glycol (PEG) crosslinker44. 
The bioprinting process can also be designed to allow 
photocrosslinking through a transparent nozzle and thus 
low- viscosity materials can be printed as stable filaments. 
Light exposure after deposition results in material flow, 
and light exposure before extrusion leads to material frac-
ture23. This technique enables the bioprinting of bioinks 
from a wide range of materials commonly used in tissue 
engineering, such as norbornene- modified HA, GelMA 
and PEG diacrylate (PEGDA)23.
a   Selective laser sintering b   Stereolithography
d   Fused deposition modellingc   3D printing
f   Two-photon polymerization
g   Solution and melt electrospinning
















































Fig. 1 | Bioprinting and bioassembly techniques.  
a | Selective laser sintering creates scaffolds by scanning a 
powder bed with a laser beam and by locally sintering the 
hit grains. b | Stereolithography creates scaffolds by 
selectively exposing a photopolymer with a light source.  
c | 3D printing is used to fabricate scaffolds by ejecting a 
binder onto a powder bed of material. d,e | Fused 
deposition modelling and 3D plotting fabricate scaffolds 
by extruding a material (either in filament or pellet form) 
through a nozzle by pressure. f | Two- photon 
polymerization is applied to develop scaffolds through 
focusing a light source on a specific point within a 
biomaterial. g | Solution and melt electrospinning are used 
to produce fibrous structures from polymer melts and 
solutions by applying electric force. Panels a–c and f are 
adapted from Peltola, S. M. et al. A review of rapid 
prototyping techniques for tissue engineering purposes, 
Annals. of Medicine (2008) reF.238, by permission of Taylor & 
Francis Ltd. Panels e and g are adapted with permission 
from reF.15, Elsevier.
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Photocrosslinkable bioinks
Light- based chemistries allow for the development 
and spatiotemporal control of materials with dynamic 
physi cochemical properties10,45. Bioinks that react in 
the presence of light are important for standard additive 
manu facturing technologies and enable the fabrication 
of 3D structures through photopatterning. Many photo-
chemical reactions are limited by oxygen attenuation of 
radicals; however, this issue can be addressed using thiol–
ene photoactivated chemistries46. Allyl- functionalized and 
thiol- functionalized linear poly(glycidol) combined with 
a photoinitiator is rapidly crosslinked upon bioprinting in 
the presence of UV light47, yielding high bioprint fidelity 
to computer design48. For example, allylated gelatin consti-
tutes a highly tuneable bioink that can be used for a variety 
of printing methods49. Similarly, the highly specific thiol–
norbornene click chemistry reaction can be exploited to 
crosslink a norbornene- modified poly(glycerol sebacate) 
as an elastomeric ink50. Thiol–ene crosslinking allows the 
design of bioprintable hydrogels with dynamic properties, 
for example, through the incorporation of enzymatically 
degradable dithiol crosslinks.
Photocrosslinkable bioinks are central to lithography- 
based biofabrication techniques51 (Fig. 2b). The multi-
scale capabilities of lithography- based bioprinting enable 
the printing of materials, such as biocompatible PEGDA 
and PEG dimethacrylate (PEG- DMA)52, that polymerize 
through a radical chain growth mechanism into single 
multiscale and multimaterial structures. In this process, 
oxygen inhibition results in the formation of a thin 
unreacted layer to which additional material is bound. 
Similarly, digital light processing can be used to fabricate 
structures on a cellular scale in PEGDA and GelMA with 
high fabrication speed53. Digital light processing can also 
be used for the patterning of high- resolution vasculature 
using GelMA scaffolds that contain HA54.
Photodegradable materials
In addition to photoactive materials used in additive 
lithographic approaches, materials can also be designed 
to locally degrade in response to a light cue, which can 
be exploited for the spatial control of material dynamics. 
By directing the focus of a nanosecond pulsed laser to 
specific volumes of a material, fine channels and micro-
fluidic networks can be patterned into hydrogels, which 
are fabricated from ECM proteins, polysaccharides or 
synthetic polymeric networks through the physical abla-
tion of covalent bonds55. For example, high- resolution 
channel structures can be patterned into PEG hydro-
gels through photolysis of synthetic peptide crosslinks 
that contain ortho- nitrobenzyl ester functionalities56. 
Such powerful, high- resolution laser- based pattern-
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Fig. 2 | Hydrogel bioprinting. a | Cell- laden hydrogel scaffolds are created by applying laser light (laser- induced forward 
transfer) or by extrusion (inkjet printing with or without robotic dispension). b | Light- induced crosslinking strategies for the 
bioprinting of photocrosslinkable bioinks are shown. Crosslinking can be triggered before (pre- crosslink), after (post- crosslink) 
or during (in situ crosslink) extrusion. Panel a is adapted with permission from reF.239, John Wiley and Sons. Panel b is adapted 
with permission from reF.23, John Wiley and Sons.
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Natural biomaterials
An important area of research is the development of 
bioinks from natural materials57, such as collagen58,59, 
decellularized ECM60–62, gelatin23,63–65, alginate66,67, 
HA23,26,34,35 and silk21,68,69, because of their inherent 
biocompatibility and the possibility to harvest the 
biochemical and biophysical cues present in natural 
cellular microenvironments to control cell behaviour70. 
Decellularized materials from a variety of tissue types 
can be formulated as bioinks and deposited using 
poly(ε- caprolactone) (PCL) supports61. Biofabrication 
enables the deposition of natural materials to repro-
duce the structural and chemical organization of native 
tissues. However, challenges remain to make natural 
materials printable and to achieve biologically relevant 
mechanical properties57.
Cells in bioinks
The term bioink refers to biomaterials that incorporate 
cells. Bioprinting of materials that contain cells faces sev-
eral challenges. Stress, such as physical or chemical per-
turbations that occur during the bioprinting process, may 
affect cell behaviour and survival. The cell density needs 
to be sufficiently high to achieve multicellular architec-
tures in the bioprinted material. The incorporation of 
cells may also alter the properties of the biomaterial, and 
finally, the material can be toxic for cells.
Cells are typically included in bioinks at concentra-
tions on the order of ten million cells per millilitre; this 
concentration corresponds to approximately ≤5% of the 
total bioink volume. At these concentrations, the pres-
ence of cells has a negligible effect on the rheological 
properties of the bioink during extrusion71. By contrast, 
the incorporation of cells affects droplet formation in 
jetting processes72,73. Bioink properties are also expected 
to change with increasing cell numbers, which is similar to 
composite material systems, in which high densities 
of included cells and particles modify mechanical and 
rheological properties74,75. Notably, how the nonlinear 
viscoelastic behaviour of cells76 impacts the properties 
of bioinks remains elusive.
Bioprinting of cell clusters39,77 and shielding of dense 
cell populations from shear stress through core–shell 
flows78 can be applied to increase the viability of cells in a 
bioprinted construct. Cell viability can also be improved 
by decoupling the cells from the bioink, for example, 
through the use of microspheres as cell carriers79 or 
the encapsulation of cells in protective microgels80. 
Ultimately, both bioink formulations and biofabrication 
processes need to be tailored to maintain cell viability to 
yield high densities of viable cells.
In vitro 3D models
In vitro 3D tissue models offer the opportunity to 
investigate the safety and efficacy of biochemical 
agents, for example, for drug development, and to 
model biological processes, such as tissue develop-
























Fig. 3 | Bioassembly of tissue- like constructs. Tubular, spherical and casquet- shaped tissue- like structures can be created 
by automated assembly of cellular spheroids or cell- laden hydrogel building blocks that fuse together because of tissue 
liquidity principles (cellular spheroids) or secondary interactions (cell- laden microgels). Reproduced with permission  
from reF.207, John Wiley and Sons.
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3D tissue models have been developed, such as cel-
lular spheroids, cell- laden hydrogel constructs, mini- 
organs and microfluidic organs- on-a- chip81,82; for 
example, in vitro models containing perfused micro-
fluidic chambers and one cell type have been used. 
More complex systems can include multiple cell types 
organized along a porous membrane with integrated 
microchannels. However, most in vitro 3D models 
created by traditional methods such as biomedical 
microelectromechanical systems cannot recreate the 
dynamic, multicellular, spatially and functionally com-
plex microscale architecture of tissues and organs83. To 
create a physiologically relevant 3D model platform, 
it is important to build tissue- like or organ- like mini-
atures that have similar structural and functional 
characteristics to native tissues.
Bioprinted in vitro tissue models
Skin. Bioprinting strategies can be employed to re- create 
multilayered skin tissue84–86. Layers of keratinocytes and 
fibroblasts can be bioprinted to construct a bioengi-
neered skin tissue composed of epidermis and dermis, 
which can be used as an in vitro skin model. For exam-
ple, a collagen hydrogel containing fibroblasts can be 
bioprinted, and melanocytes and keratinocytes can 
be sequentially deposited on top of the fibroblast layer to 
a
c
b3D printing 22ºC Release 37ºC
1 cm 1 cm 10 mm 10 mm
0.1 mm 0.2 mm
Structures within support gelFreestanding structures













Fig. 4 | Bioprinting in support materials. Self- healing hydrogels can be used as support media for bioprinting to enable 
the 3D fabrication of structures. a | A gelatin slurry can be used for the fabrication of hydrogel structures with large void 
spaces, for example, heart constructs. The hydrogel (green) is extruded and crosslinked within the gelatin slurry support 
(yellow). The 3D object is then released through melting of gelatin at 37 °C. Using this method, an embryonic chicken heart 
can be fabricated on the basis of a 3D computer- aided design model. The bioprinted tissue construct made using 
fluorescent alginate (green) exhibits the same internal trabecular structure as an embryonic chicken heart. b | A granular 
medium composed of carbomer microgels enables 3D printing of multiscale hierarchical structures, for example, 
continuous branched tubular networks of hollow vessels. The network of hollow tubes shown in the microscopy images 
was printed using polyvinyl alcohol, starting from a 25 mm diameter circular base and tapering to 27 capillaries with a 
diameter of 100 µm and a wall thickness of 100 µm. The insets show confocal cross sections. c | Hydrogels crosslinked by 
non- permanent, shear- thinning and self- healing bonds support the printing of high- resolution structures. Support 
material or printed ink can be removed after processing to produce complex structures that are freestanding or that 
contain voids and channels. The confocal microscopy images show a freestanding 3D tetrahedron made of 
photocrosslinked methacrylate- modified hyaluronic acid (blue), a rhodamine- labelled spherical structure (red) in an 
unlabelled support hydrogel and a fluorescein- labelled filament (green) with a rhodamine- labelled spiral (red) in an 
unlabelled support hydrogel. Panel a is adapted from reF.32, CC- BY-4.0. Panel b is adapted from reF.33, CC- BY-4.0.  
Panel c is adapted with permission from reF.34, John Wiley and Sons.
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mimic the architecture of native skin84. A 3D human skin 
wound model can be engineered through the bioprint-
ing of multilayered skin tissues on a non- planar PDMS 
surface86. Such in vitro skin models can be used to study 
skin corrosion, irritation, permeability and the safety of 
chemical compounds.
Liver. Bioprinted hepatic models can serve as a plat-
form for the investigation of physiological phenom-
ena in the liver and for the accurate prediction of 
drug and toxic responses9,83,87–89. A liver micro- organ 
chamber device can be engineered by bioprinting a 
hepatocyte- laden alginate hydrogel in a microfluidic 
chamber, thereby creating a physiologically relevant 
pharmacokinetic model. This device can be operated 
at continuous perfusion flow while maintaining cell 
viability and hepatocyte- specific functions such as 
albumin and fibrinogen production. A human induced 
pluripotent stem cell (hiPSC)-laden alginate bioink 
can be bioprinted into a 3D mini- liver by the use of a 
dual- head jetting bioprinter7. The hiPSCs in the bio-
printed construct were differentiated into hepatocyte- 
like cells, which expressed hepatocyte- specific markers 
and secreted albumin. The function of 3D liver models 
can be evaluated through the analysis of protein syn-
thesis (for example, fibrinogen and prothrombin), bile 
acid synthesis for digestion and the transformation of 
carbohydrates to fatty acids90–92.
Lung. In vitro 3D lung models have been considered 
for high- throughput screening and drug discovery93,94. 
A human in vitro air–blood barrier model, composed 
of three layers of endothelial cells, basement mem-
brane and lung epithelial cells, can be fabricated using 
an extrusion- based bioprinter95. The 3D bioprinting 
process enables the construction of very thin and uni-
form layers of cells and Matrigel (as the basement mem-
brane), which resemble the physiology and function of 
native lung tissue. A more realistic lung model can be 
achieved through introducing simulated physiological 
breathing motion by cyclic mechanical strain96.
Heart. Multimaterial bioprinting of sacrificial dex-
tran, flexible thermoplastic polyurethane (TPU), con-
ductive carbon black nanoparticles (CB) and PDMS 
allows for the creation of a cardiac microphysiological 
device5. In this device, TPU microfilaments guide car-
diomyocyte alignment, and the deposited conductive 
CB–TPU composite is able to measure tissue contrac-
tion. Functional assessment of the in vitro cardiac 
tissue model includes cardiac cell synchronization, 
beating behaviour, electrophysiological properties and 
contractile force measurement97,98.
Kidney. An in vitro model of the human proximal 
tubule interstitial interface can be fabricated by bio-
printing of renal fibroblasts, endothelial cells and pri-
mary human renal proximal tubule epithelial cells99. 
The in vitro proximal tubule tissue can be used to 
study the mechanisms of nephrotoxicity and to inves-
tigate epithelial–interstitial interactions involved in 
kidney pathogenesis.
Body- on-a- chip. Body- on-a- chip (or human- on-a- 
chip) devices aim to integrate multiple human tissue 
models within microfluidic devices100 to mimic human 
physiology. Bioprinting strategies101 can contribute 
to the development of such devices, for example, by 
providing a miniature 3D heart model that actively 
pumps fluid through the entire system and/or a 3D 
lung model to oxygenate, a 3D liver model to metab-
olize and a 3D kidney model to purify the circulating 
blood substitute.
Cancer models. In vitro 3D tumour models, such as 
cancer cell spheroids, are frequently used for ther-
apeutic screening. Cellular spheroids mimic the 
cell–cell and cell–matrix interactions in the tumour 
microenvironment102,103. However, such models do 
not recapitulate all aspects of the complex tumour 
microenvironment, such as the associated vasculature 
and neural network. Therefore, bioprinting techno-
logy can be employed to create multicellular, control-
lable and reproducible tumour models. For example, 
a 3D cervical tumour model can be fabricated by the 
extrusion printing of HeLa cells (a human cell line 
derived from cervical cancer tissue)104. Bioprinted cancer 
cells form spheroids in the 3D bioprinted microenvi-
ronment and exhibit high chemoresistance. A bioprinted 
ovarian tumour model that features a multicellular 
acini structure consisting of human ovarian cancer 
cells and normal fibroblasts can be engineered using 
inkjet bioprinting. This technique allows for precise 
control of cell density, droplet size and the spatial dis-
tance between the droplets. The bioprinted ovarian 
tumour model has been applied for high- throughput 
screening105. A breast tumour model can be created by 
the direct bioprinting of cell spheroids composed of 
breast cancer cells in the core, mammary fibroblasts 
and adipose cells into multi- well plates106. Such bio-
printed tumour models provide an in vitro tool for the 
development of anticancer therapeutics.
Bioassembled in vitro tissue models
Bioassembly involves the integration of various- shaped 
cellular building blocks to reconstruct organomimetic 
macroscopic cellular tissues. Cell- laden hydrogels are 
commonly used as building blocks because their shapes 
can be varied using microfluidic and microfabrication 
techniques. Hydrogel- based building blocks are catego-
rized into point- shaped, line- shaped and plane- shaped 
cell- laden structures107.
Point- shaped structures. Point- shaped cell- laden struc-
tures are easily prepared by culturing cells with hydrogel 
beads made of alginate108,109, PEG110,111 or collagen112,113. 
Such structures are fabricated using microfluidic 
devices with T junction, flow- focusing and nozzle- 
shaped microchannels. Moulding is a popular method 
for the assembly of cell- laden beads. In this method, 
the beads are packed into a mould and integrated 
through cell adhesion, resulting in the construction 
of millimetre to centimetre- sized tissues with specific 
shapes defined by the shape of the mould108,111,112,114,115 
(Fig. 5a). Moulding of point- shaped cell- laden structures 
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a   Point-shaped cell-laden structure
b   Microfluidic manipulation c   Optically induced dielectrophoretic manipulation
d   Line-shaped cell-laden structure








































Fig. 5 | Bioassembly of macroscopic tissue structures. a | Cell- laden beads are assembled by moulding in  
poly(dimethylsiloxane). The microscopy image shows a human doll- shaped tissue made of fluorescently  
labelled fibroblasts (green) and collagen beads. b | Point- shaped cell- laden structures containing human  
epithelial cells transfected with green fluorescent protein and human embryonic kidney cells transfected  
with red fluorescent protein can be delivered and subsequently assembled by microfluidic flow. c | Optically  
induced dielectrophoretic force- based manipulation for the assembly of point- shaped cell- laden structures  
can also be used. The device consists of a top glass substrate with transparent and conductive indium oxide  
(ITO) coating, a working chamber and a bottom ITO glass substrate coated with a thin photoconductive  
hydrogenated amorphous silicon (a- Si:H) film. The microscopy image shows assembled point- shaped structures 
containing fibroblasts (green), human embryonic kidney cells (blue) and human metastatic mammary carcinoma  
cells (red). d | Assembly of line- shaped cell- laden structures is also used. Helical tubes are formed by reeling  
of a hepatocyte- laden and a fibroblast- laden fibre with a rod. A T- shirt-shaped structure is formed by weaving  
cell- laden fibres with fibroblasts (green), hepatocytes (red) and small lung carcinoma cells (blue). Blood vessel- 
 like structures can be fabricated by dissolving smooth muscle cell- laden and endothelial cell- laden alginate  
gel fibres in a collagen block. e | Assembly of plane- shaped cell- laden structures is also used. Cell- laden sheets  
are stacked by sandwiching a hepatocyte- laden sheet (green) between endothelial cell- laden sheets (red).  
Tubular structures are created by rolling of a cell- laden sheet containing endothelial cells (green), smooth  
muscle cells (blue) and fibroblasts (magenta). The tubular structure has multiple cell layers. Panel a is  
reproduced from reF.117, Macmillan Publishers Limited. Panel b is adapted with permission from reF.118,  
John Wiley and Sons. Panel c is adapted from reF.121, Macmillan Publishers Limited. Panel d is adapted with  
permission from reF.123, American Chemical Society. Panel e is adapted with permission from reFs128,129,  
John Wiley and Sons.
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has been applied for the construction of hepatic tis-
sues112, connective tissues112,115 and neural tissues114, 
for biological analyses in 3D culture conditions (for 
example, albumin secretion from hepatic tissue) and to 
investigate cell–cell interactions (for example, 3D neu-
ral networks). Organoids are point- shaped cell- laden 
structures that contain cellular aggregates of patient- 
derived stem cells and possess diameters up to several 
millimetres. Organoids are promising macroscopic 
models for the physiologically relevant reconstruction 
of diseases116, and their assembly will be facilitated by 
bioassembly using moulds. Point- shaped cell- laden 
structures that contain different types of cells can 
be precisely arranged within macroscopic tissues by 
applying microfluidic and dielectrophoretic forces in 
microchannels in a high- throughput manner. This 
approach enables the spatial control of co- culture of 
different tissues117,118 (Fig. 5b,c).
Line- shaped structures. Line- shaped cell- laden struc-
tures, such as cell- laden fibres and tubes, are formed 
using laminar flow and nozzle- shaped microchannels, 
alginate119,120 and/or collagen121,122. The assembly of cell- 
laden fibres and tubes is facilitated through rotation of 
rods or plates at the outlet of the microchannels, allow-
ing the reeling of fibres and tubes120,121. Using the reeling 
method, the different cell- laden fibres can be arranged 
on support structures in 3D (Fig. 5d). Alternatively, 
weaving can be applied without support materials121. 
Using the weaving method, centimetre- sized 3D cellu-
lar tissues can be constructed on the basis of precisely 
arranged cell- laden fibres. For example, hepatic tis-
sues can be formed through the reeling and weaving 
of hepatocyte- laden fibres and fibroblast- laden fibres. 
Such 3D co- culture conditions promote cellular func-
tions (for example, albumin secretion). Furthermore, 
cell- laden fibres and tubes can be used to create lumen 
structures by embedding vascular endothelial cells in 
the fibres and tubes. The vascular channels, formed by 
the endothelial cells, provide nutrients and oxygen123,124 
(Fig. 5d). The mechanical flexibility of cell- laden fibres 
and tubes allows for the formation of wavy- shaped 
vascular channels at arbitrary locations in the tissue. 
Thus, line- shaped cell- laden structures can be used 
as cellular building blocks for the construction of 
large- scale, 3D, vascularized tissues.
Plane- shaped structures. Plane- shaped cell- laden struc-
tures, for example, cell- laden sheets, can be fabri cated 
using temperature- responsive culture dishes, micro-
fluidic flat channels or sacrificial layers125–127. Stacking 
enables the assembly of cell- laden sheets, for exam-
ple, to produce macroscopic hepatic tissues, in which 
hepatocyte- laden sheets are sandwiched between 
endothelial- laden sheets128 (Fig. 5e). Alternatively, roll-
ing can be used to form tubular tissues. A cellular sheet 
containing precise arrangements of endothelial cells, 
smooth muscle cells and fibroblasts can be rolled up 
into a tube, resulting in a millimetre- sized hierarchical 
model of a vascular tube129,130 (Fig. 5d). Such plane- shaped 
cell- laden structures can be applied for the construction 
of the cellular tissues with simple shapes.
Tissue and organ regeneration
Biofabrication strategies can be applied to create clini-
cally applicable tissue constructs that can be implanted 
in the body. Biofabrication has the potential to engineer 
heterogeneous tissue structures, including shape- based 
tissues such as bone, cartilage, skin and cornea; organi-
zed tissues such as skeletal muscle and cardiac and 
neural tissues; composite tissues such as osteochondral 
and musculotendinous tissues; and whole organs with 
vasculature and functional inner structures such as the 
kidney and heart (Fig. 6). Biofabrication offers the oppor-
tunity to reconstruct the structural and ultimately the 
functional complexity of human tissues through incor-
porating materials, cells, biochemical and biophysical 
cues to specifically design tissue shape, organization, 
structure and integration.
Shape
Additive manufacturing technologies, such as direct 
metal laser sintering or electron beam melting, are 
already clinically in use, for example, for the fabrica-
tion of patient- specific metal implants131. Bioprinting 
technologies can be used to engineer patient- specific 
implants, for example, for bone grafting, and can take 
into account anatomic differences, defect size and 
patient- specific morphology of bone pathologies132–134. 
Furthermore, medical imaging techniques, such as 
computed tomography and magnetic resonance imag-
ing can be applied to inform the customized design of 
personalized engineered tissues, for example, to fabricate 
bone constructs composed of osteoconductive materials 
such as hydroxyapatite and β- tricalcium phosphate as 
well as osteogenic cell types135–138. Similarly, heart valves, 
intervertebral discs and menisci can be constructed 
using biofabrication techniques139–141. The possibility 
to design personalized constructs constitutes a major 
strength of biofabrication technologies.
Current cartilage tissue engineering approaches can 
only partially recreate healthy and functional cartilage142 
owing to difficulties in engineering the zonal differences 
in articular cartilage that have distinct cellular composi-
tions143. Bioprinting can be applied to fabricate stratified 
cartilage constructs by regenerating the patient- specific 
size and shape of individual lesions144–148. Bioprinted car-
tilage exhibits similar biomechanical and biochemical 
properties to native cartilage and is well integrated with 
surrounding cartilage tissue as assessed by ECM deposi-
tion in vitro146. Auricular cartilage, for example, as found 
in the ear, can be reconstructed by an extrusion- based 
bioprinting process using sodium alginate, silver nano-
particles and chondrocytes arranged in an ear- shaped 
geometry around a conductive, sound- translating coil. 
This bionic ear can translate sound waves into an elec-
trical output149. Furthermore, an extrusion- based bio-
printing system has been applied to fabricate a human 
ear- shaped cartilage tissue construct138. The shape of the 
ear was well maintained for 2 months in a subcutaneous 
mouse model, as confirmed by glycosaminoglycan and 
collagen type II expression. Alternatively, chondrocyte- 
laden alginate beads can be used for the construction 
of cartilage tissues. For example, chondrocyte- laden 
beads that are assembled with the shape of the cartilage 
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defects in the knee can serve as grafts150,151. Skin is com-
posed of thin layers of epidermis and dermis. In situ 
3D bioprinting approaches can be applied to construct 
tissue replacements for large- scale skin wounds and 
burns, which have been successfully tested in mice152. 
In this approach, amniotic fluid- derived stem cells in 
a fibrinogen and collagen hydrogel are bioprinted over 
the wound area by the use of extrusion- based printing. 
This in situ skin bioprinting approach delivers cell- laden 
hydrogels directly onto the wound, achieving uniform 
wound coverage, thus providing an effective treatment 
for large- scale skin wounds.
Cornea also has a plane- shaped tissue structure 
composed of three layers: epithelium, stroma and 
endothelium. Corneal epithelial disorders caused by 
severe disease or trauma can result in corneal opacity 
and thus loss of visual acuity. Corneal epithelial cell 
sheets prepared by culturing limbal stem cells on a 
temperature- responsive culture dish can be directly 
placed onto the damaged tissue to reconstruct the cor-
neal epithelium and to recover the transparency of the 
cornea153,154. Alternatively, oral mucosal epithelial cell- 
laden sheets can be used for the treatment of bilateral 
corneal deficiency153,154.
Tissue organization
Skeletal muscle accounts for ~40% of the human body 
weight155 and is composed of highly aligned muscle 
fibres. Fibre organization is essential for muscle con-
traction and force generation156. Extrusion- based 
printing can be applied to recreate the spatial organi-
zation of skeletal muscle fibres through the fabrication 
of micrometre- scale muscle- like bundles (~400 µm 
in diameter)138. The bioprinted muscle construct then 
matures into functional muscle tissue once integrated 
with the host nerves in vivo.
Similarly, cardiac tissue features complex myocardial 
organization to enable contractility97. Laser- induced 
forward transfer cell bioprinting can be applied to 
construct a cardiac patch exhibiting spatially organ-
ized patterns of human mesenchymal stromal cells 
(hMSCs) and endothelial cells on a poly(ester urethane) 
urea matrix157. Implantation of the cardiac patch into 
an infarcted rat heart promotes vascularization and 
improves cardiac function. A bioprinted, porous half- 
heart structure containing primary feline adult and 
H1 cardiomyocytes in alginate can be produced using 
a modified inkjet printing method158. The deposited 
cells retain their viability in the tissue construct and 
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Fig. 6 | 3D bioprinting of tissues and organs. Biomedical applications based on design concept and printing resolution. 
Constructs of various shapes and sizes can be made: human- scale bone, ear- shaped and nose- shaped structures can be 
fabricated. At the level of tissue organization, cellular alignment can be achieved for skeletal and cardiac muscle 
constructs. Composite tissues, such as osteochondral (bone–cartilage) and musculotendinous (muscle–tendon), can be 
fabricated by sequentially patterning multiple components. Functional inner structures, such as microvasculature and 
nephrons, are required for whole organ bioprinting. The ear and skeletal muscle images are reproduced from reF.138, 
Macmillan Publishers Limited. The osteochondral tissue image is reproduced by permission from authors Francois 
Berthiaume and Jeffrey Morgan, 3D tissue engineering, Norwood, MA: Artech House, Inc., (2010). Copyright 2010 by Artech 
House, Inc. The musculotendinous tissue image is reproduced with permission from reF.163, IOP Publishing. The 
microvasculature image is reproduced with permission from reF.31, John Wiley and Sons. The nephron image is reproduced 
from reF.8, CC- BY-4.0.
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exhibit contractility upon electric stimulation in vitro. 
Human cardiac- derived cardiomyocyte progenitor cells 
can also be bioprinted, resulting in ~90% cell viability 
and cardiac tissue maturation for 7 days in culture159. 
Multiple cell types, including hiPSC- derived cardi-
omyocytes, human smooth muscle cells and human 
endothelial cells, can be seeded into a bioprinted uni-
axially oriented gelatin scaffold to produce an hiPSC- 
derived cardiac muscle patch160. Similarly, bioassembly 
approaches can be applied for cardiac regeneration, for 
example, cardiomyocyte- laden, skeletal myoblast- laden 
or hMSC- laden sheets can be implanted into damaged 
rat hearts to improve cardiac performance153.
Composite tissues
Simple- shaped tissue constructs offer the opportunity 
to replace parts of damaged tissue. However, such engi-
neered scaffolds cannot recreate complex composite 
tissue types161. An anatomically correct osteochondral 
tissue construct composed of PCL and hydroxyapatite 
can be engineered using bioprinting. The bioprinted 
osteochondral tissue can be implanted to repair the 
entire articular surface of a synovial joint in a rabbit 
model162. The regeneration of musculotendinous tissue 
represents a different challenge because of its mechanical 
function. To recreate the composite nature of the tissue 
and to enable mechanical function, four different tissue 
components are bioprinted into an integrated muscle–
tendon unit (MTU) construct163. The MTU construct 
is composed of mechanically heterogeneous polymeric 
materials that are elastic on the muscle side and stiffer 
on the tendon side. Additionally, cells are distributed in 
a tissue- specific manner, with myoblasts on the muscle 
side and fibroblasts on the tendon side. The cells main-
tain high cell viability and orientation and express genes 
associated with musculotendinous junctional tissue 
in vitro, demonstrating the possibility to bioprint a 3D 
heterogeneous tissue construct with localized biological 
and biomechanical characteristics.
Inner structures
The incorporation of microvascular networks and func-
tional inner structures in bioengineered constructs is 
crucial for whole organ bioprinting164. The limit of oxy-
gen and nutrient diffusion for cells to survive in vivo is 
100–200 µm (reFs165–167). Building a functional vascula-
ture within 3D tissue constructs remains challenging. 
Microtubular structures can be created using micro-
fluidics and patterns to guide tissue invasion and vascu-
larization in vivo168,169. Bioprinting can be employed to 
create microchannels that contain layers of endothe-
lial cells. A sacrificial material, such as carbohydrate 
glass, can be used to provide a template for printing. 
Once removed, a microchannel remains, which mimics 
vascular tissue; however, this tissue is limited in size 
owing to difficulties associated with direct perfusion36.
Alternatively, 3D tissue constructs can be prefabri-
cated with vasculature and printed using multiple cell 
types and ECM proteins170,171. Human microvascular 
endothelial cells self- align inside printed biomaterial- 
based microchannels and form a confluent microvas-
cular lining. Engineered vascular tubes fabricated by 
bioassembly of cell- laden sheets have been used for 
arterial bypass through anastomosis of the tubes172. 
However, connecting the vasculature to the host 
circulatory system remains a challenge173.
Functional inner structures, such as the nephron and 
hepatic lobules, can also be fabricated by bioprinting. 
For example, 3D human renal proximal tubular struc-
tures containing proximal tubular epithelial cells can be 
generated8. The tubule- like structure is circumscribed 
by proximal tubule epithelial cells and actively perfused 
through the open lumen. The bioprinted epithelial 
barrier can be disrupted by introducing nephrotoxin or 
ciclosporin A.
The integration of nerves is essential to render bio-
engineered tissues functional in vivo. Neuron- laden colla-
gen fibres can be used for the formation of neural tissues 
exhibiting pathways of aligned neurons in spatially dis-
tinct areas174. The neuron- laden collagen fibres can then 
be used to connect different brain regions, for example, 
the hippocampal–prefrontal and visual pathways.
Tissue encapsulation
Advances in biofabrication techniques and materials 
science have enabled the fabrication of complex tissue 
structures in vitro; however, translation to the clinic 
still faces challenges, such as the fibrotic encapsula-
tion of implanted constructs due to the foreign body 
response, which results in protein deposition and often 
failure of the implant. Alginate- based and PEG- based 
hydrogels have the potential to mitigate the foreign 
body response175–177. These hydrogels are  semipermeable 
with a diffusion cut- off that shields the implant from 
the immune cells but enables nutrients, waste and cell- 
secreted products to pass through; for example, embed-
ded hydrogel beads can be simply prepared and injected. 
Beads with diameters >1.5 mm (reF.178) or triazole–
thiomorpholine dioxide modifications of alginate enable 
the suppression of the host immune response176,179.
Using this method, cells in the islets of Langerhans, 
which secrete insulin in response to the glucose con-
centration in the blood, can be combined with hydro-
gel beads and implanted to replace diabetic pancreatic 
islets177–179. The hydrogel beads are used to protect the 
islet cells from the host immune response, and thus 
the tissue constructs maintain viable and secrete insu-
lin for a long period of time in the body of the patient, 
even in case of xenotransplantation180,181. Alginate beads 
can also be integrated with hepatic tissue and implanted 
to provide continuous secretion of albumin in the 
body182,183. Alternative to beads, alginate gel fibres and 
sheets containing pancreatic tissue have been proposed 
as retrievable grafts owing to their single- unit and con-
nected structures121,122,184,185. Pancreatic islets can also be 
combined with alginate gel fibres and sheets and can 
secrete insulin to regulate blood glucose levels.
Challenges and opportunities
Conventional bioprinting and bioassembly spur from 
additive manufacturing and self- assembly processes15. 
Despite the many advantages, there are still a few lim-
itations that need to be addressed to achieve complex 
tissue regeneration and ultimately organ regeneration.
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Tissue complexity
Progress in software design to control additive manufac-
turing systems has led to the implementation of scripts to 
calculate complex pore network architectures and multi-
material deposition. However, the majority of fabricated 
biological constructs are still characterized by simple 
architectures, which do not resemble the complexity 
of human tissues. Complex pore network architectures 
enable the recreation of functional mechanical prop-
erties, mimicking the mechanical behaviour of human 
tissues. For example, structures with variable Poisson 
ratios186 lead to better vascular tissue regeneration than 
constructs with homogeneous contraction:relative 
expansion ratios54,187. Such engineered structures could 
be designed to enable large deformations188, storage of 
energy189 or magnetic responsiveness190, endowing tis-
sues with extended functionalities. Moreover, modelling 
can be applied to predict and design network organiza-
tion of tissues and organs; for example, the vascular tree 
network can be modelled191,192 on the basis of theoretical 
cell aggregate fusion mechanisms193,194. Informing the 
experimental design of a given tissue construct through 
computational modelling will certainly improve the 
properties and function of biofabricated tissues.
Scalability and manufacturing time
Scalability and long manufacturing times of bioprinted 
constructs remain issues for clinical translation. Vat 
photopolymerization printing methods, such as ste-
reolithography, digital light processing and continu-
ous liquid interface production (CLIP), are additive 
manufacturing technologies based on photosensitive 
materials, which enable shorter lead fabrication times 
than other biofabrication technologies195–200. For exam-
ple, CLIP allows for the fabrication of cubic centimetre- 
sized objects in minutes by controlling the amount of 
oxygen present at the interface between the photosen-
sitive polymer and the light projector (Fig. 7). Therefore, 
the printing process is dependent only on the curing 
rate and viscosity of the polymer. The development of 
biomedical- grade photopolymers will pave the way for 
the bioprinting of large biological constructs using these 
additive manufacturing technologies.
Levitation
Bioacoustic levitation can be used to assemble cell- 
laden constructs at high speed (Fig. 8). Bioacoustic 
printing enables the patterning of cell- laden hydro-

































Fig. 7 | stereolithography and continuous liquid interface production. a | A 3D computer- aided design (CAD) file is first 
created for a given structure and then sliced. b | Continuous liquid interface production (CLIP) requires fewer steps than 
stereolithography (SL A) to assemble the designed structure. c The fabrication process includes placement of the build 
elevator on the resin, subsequent UV exposure to selectively cure the resin, separation of the cured resin from the oxygen- 
impermeable window , mechanical recoating of the resin and, finally , repositioning of the build elevator to repeat the 
process until the part is fully printed. CLIP uses a constant liquid interface enabled by an oxygen- permeable window , 
which eliminates the need for the last three steps. Adapted with permission from reF.197, Proceedings of the National 
Academy of Sciences.
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coherently interfering with each other, can be used to 
initiate cell levitation in a resonant chamber contain-
ing a cell- laden hydrogel, enabling the deposition of 
cell layers in <10 seconds and thus the fabrication of 
constructs with high cell density (Fig. 8a). The depos-
ited cells remain viable and proliferate for up to 7 days. 
However, fabrication times are an order of magnitude 
slower than those of conventional bioprinting technol-
ogies202. Moreover, bioacoustic levitation is limited by 
the use of one single cell population and has thus far 
been used only with fibrin hydrogels201. Alternatively, 
magnetic levitation assembly can be used to manipu-
late different cell types203. Using this method, cells can 
be sorted by specific density in 3D through levitation 
in an equilibrium plane between magnetic and buoy-
ancy forces. Cells remain viable for up to 5 days in vitro 
following magnetic levitation sorting. Levitation tech-
nologies could potentially be extended to enable the 
manipulation of hydrogels, which, in combination with 
other bioprinting approaches, would facilitate the fab-
rication of integrated systems, such as gel- in-gel and 
nanocolloidal systems32,33. However, validation of lev-
itation technologies in longer in vitro studies and in 
animal models is necessary to assess the potential for 
therapeutic applications.
Levitation could further be used to assemble cellular 
aggregates or cell- laden microgels for the engineering 
of biological building blocks (Fig. 8b). Microgels provide 
a flexible platform because they can be synthesized 
with different built- in biological cues and cell types204. 
Furthermore, microgels allow for the fabrication of 
materials that have proved challenging to be processed, 
such as silicone, which might be relevant for fields 
such as soft robotics205. Cellular or cell- laden micro-
gel building blocks can be self- assembled through 
cell–cell206 or secondary material interactions207. For 
example, DNA modification of these biological build-
ing blocks can trigger and program self- assembly 
a priori208,209. Alternatively, cell- laden microgels can be 
assembled into more complex structures by the use of 
magnetically actuated microrobotic systems210. Such 
micro robots contain magnetic materials that can be 
actuated by electromagnets, which are controlled by 
high- level user algorithms. The robots can apply forces 
of up to 70 nN to pick and place PEG and GelMA cell- 
laden hydrogels, and the incorporated cells maintain 
viability for up to 7 days after processing.
Future perspective and conclusions
Despite the rapid pace with which biofabrication 
strategies are being developed in different labora-
tories and companies worldwide, fabricating a fully 
functional tissue or organ is still beyond reach. 
Several challenges remain to produce functional 
organs for clinical applications and as therapeutic 
3D models. Vascularization and innervation of engi-
neered tissues will be key milestones for the con-
struction and engraftment of functional constructs. 
Several strategies have already been explored to ena-
ble vascularization37,54, but only limited progress has 
been made in the design of innervation. Furthermore, 















































Fig. 8 | Bioacoustic levitation. a | A densitometry platform for the bioacoustic 
levitation of cells is shown. b | Owing to magnetic induction (B) and gravity (g),  
cells are levitated in the channel and focused in a plane in which magnetic forces 
(Fmag) and buoyancy forces (Fb) are in equilibrium. The magnetic susceptibility  
of the medium (Xm) has to be substantially larger than the magnetic susceptibility 
of the cells (Xc), such that different cell types with different densities (tumour  
cells (TCs), white blood cells (WBCs) and red blood cells (RBCs)) can be separated.  
c A bioacoustic levitation bioprinting process to construct 3D neural constructs  
is shown. Neuroprogenitor cells in a fibrin hydrogel are placed in the levitation 
chamber. An acoustic ceramic generates incident waves, which coherently 
interfere with the waves reflected from the glass reflector, which is placed on  
top of the chamber. The resultant standing waves induce cells to levitate,  
resulting in 3D multilayer constructs of differentiated neural cells. Panels  
a and b are reproduced with permission from reF.203, Proceedings of the National 
Academy of Sciences. Panel c is adapted with permission from reF.202, John Wiley 
and Sons.
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response needs to be fully elucidated to ensure func-
tional engraftment upon implantation of biofabricated 
constructs176,211,212. For the recreation of whole organs, a 
detailed biological understanding of tissue- specific cell 
populations and phenotypes is required to replicate the 
anatomy and physiology of the organ, including cell–cell 
and cell–ECM communication, as well as morphogene-
sis. For example, complex artificial niche- like environ-
ments in combination with two- photon polymerization 
enable fundamental studies of cell–ECM interactions 
at a submicrometre resolution213–215. Biological studies 
need to be accompanied by technological development 
to ultimately achieve a high degree of similarity between 
native tissues and organs and biofabricated constructs. 
Biomaterials need to be developed that mimic the 
dynamics of the ECM, for example, by exploiting hydro-
philic and hydrophobic interactions216, electrical prop-
erties217 or molecular self- assembly218. Experimental 
observations need to be coupled with multiparametric 
models of bioink viscosity to understand biomaterial 
behaviour during tissue fabrication. The fabrication of 
constructs comprising multiple materials, for exam-
ple, by exploring microfluidic technologies219,220, will 
allow for the integration of different cell types and 
properties within one engineered tissue. Ultimately, 
the aim is to fabricate constructs that mimic native 
tissue organization221,222.
The deposition into or onto support materials ena-
bles bioprinting of materials that rapidly flow after 
extrusion. For example, a co- printed thermoplastic 
support framework into which soft materials can be 
deposited138,223 facilitates the fabrication of organ- scale 
constructs from soft materials. Liquid support systems, 
for example, the deposition of aqueous droplets into 
an oil reservoir216, can be applied for the bioprinting 
of materials with cells224. The immiscibility of the bio-
printed ink with the oil support and the stabilization 
of the droplet by lipids in the oil phase enable the for-
mation of stable, self- supported, droplet- based struc-
tures. By integrating low- gelling temperature agarose 
and cells in the aqueous ink, cooling can be used to 
trigger gelation, stabilizing the structure upon removal 
from the oil224.
The fabrication of macroscopic tissues and organs 
further requires a large number of cells, which are often 
challenging to obtain or produce. For generating large 
numbers of specialized and patient- specific cells, hiP-
SCs hold great potential, and biomaterials can provide 
an adequate, controlled environment for cell expansion 
and differentiation by dynamically displaying the correct 
biochemical and biophysical cues and by promoting 
cell viability225,226.
Simple tissue defects can already be treated with 
biofabricated scaffolds exhibiting hierarchical struc-
tural properties or engineered surface properties to 
steer cell activity. However, complex biofabricated 
constructs require maturation in bioreactors and 
cannot yet be directly implanted in patients after fab-
rication. Technologies need to be developed to mon-
itor and control the behaviour of processed cells, the 
maturation of assembled tissues and physicochemical 
changes, such as shrinking, swelling, deformation and 
degradation, that occur in the supporting biomate-
rials during the fabrication and maturation process. 
Adhesion, migration, proliferation, differentiation 
and apoptosis of cells also need to be monitored and, 
ideally, controlled, and the biological building blocks 
need to be correctly combined, fixed and connected 
in 3D. For example, impedance measurements of inte-
grated carbon nanotubes allow for the monitoring of 
cell adhesion, spreading and density in 3D227. Similarly, 
sol–gel formulations, fabricated by inkjet printing, 
enable the integration of pH sensors into cell- laden 
hydrogels228. Tissue maturation can be followed by 
assessing functional markers in real time, for exam-
ple, by integrating biofabrication technologies with 
electronically active biomaterials or materials with 
intrinsic optoelectronic properties229,230.
Tissues can also be regenerated in situ by the use 
of biomaterials that actively trigger the regeneration 
process, for example, for musculoskeletal231,232 and car-
diovascular233,234 applications, possibly in combination 
with biofabrication strategies235. The development 
of dynamic materials (for example, shape memory 
materials or supramolecular hydrogels) compatible 
with bioprinting will facilitate 4D printing236, exploit-
ing temporal external stimuli during processing or 
after implantation237.
The biofabrication and medical application of a 
fully functional organ will depend on fruitful col-
laborations across many disciplines, encompassing 
engineering, materials science, biology, medicine and 
business administration, to ensure not only progress 
in fundamental science but also clinical translation 
through commercialization. The biofabrication com-
munity has already developed tissue constructs for 
preclinical models and is working towards upscal-
ing to human- scale tissues. We envision that tissues 
such as biofabricated skin, cartilage and vascular and 
cardiac patches, as well as peripheral neural grafts, 
have the potential to reach the clinic within the next 
5–10 years.
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